Systemic inflammation in acute cardiorenal syndrome: an observational pilot study
C Linhart, C Ulrich, D Greinert, S Dambeck… - ESC heart …, 2018 - Wiley Online Library
Aims Acute cardiorenal syndrome (CRS) with and without consideration of the volume state
was assessed with regard to inflammatory parameters. Methods and results Blood samples …
was assessed with regard to inflammatory parameters. Methods and results Blood samples …
Subclinical cognitive impairment in chronic kidney disease is associated with frailty and reduced quality of life
R Greinert, D Greinert, AL Eger… - Nephrology Dialysis …, 2023 - academic.oup.com
Background Cognitive impairment (CI) in chronic kidney disease (CKD) is highly prevalent
and is associated with multiple limitations to patients as well as a higher mortality, more days …
and is associated with multiple limitations to patients as well as a higher mortality, more days …
Oliguric acute kidney injury as a main symptom of bradycardia and arteriosclerosis resolved by pacemaker implantation: a case report
…, D Radler, A Tamm, D Greinert, R Greinert… - Journal of Medical Case …, 2014 - Springer
Introduction Cardiovascular comorbidities regularly determine renal function. We report a
case of acute kidney injury (Acute Kidney Injury Network stage 3) due to an intermittent third-…
case of acute kidney injury (Acute Kidney Injury Network stage 3) due to an intermittent third-…
COVID-19 and acute kidney injury in German hospitals 2020
V Walendy, M Girndt, D Greinert - Plos one, 2022 - journals.plos.org
Introduction The SARS-CoV-2 pandemic is a major challenge for patients, healthcare
professionals, and populations worldwide. While initial reporting focused mainly on lung …
professionals, and populations worldwide. While initial reporting focused mainly on lung …
Risk of overanticoagulation during acute kidney injury in patients treated with vitamin K antagonists
L Süfling, D Greinert, M Girndt - Nephrology Dialysis …, 2022 - academic.oup.com
Background Vitamin K antagonists (VKAs) are still in use for oral anticoagulation, but not all
indications allow their replacement by direct oral anticoagulants. Although formal dose …
indications allow their replacement by direct oral anticoagulants. Although formal dose …
COVID-19 and acute kidney injury in German hospitals 2020 (preprint)
V Walendy, M Girndt, D Greinert - 2021 - pesquisa.bvsalud.org
Introduction The SARS-CoV-2 pandemic is a major challenge for patients, healthcare
professionals, and populations worldwide. While initial reporting focused mainly on lung …
professionals, and populations worldwide. While initial reporting focused mainly on lung …
[HTML][HTML] Impact of the SARS-CoV-2 Pandemic on the Treatment and Care of Patients With Chronic Kidney Disease in Germany: Results of a Nationwide Survey
V Walendy, M Girndt, DF Greinert - 2020 - europepmc.org
… Greinert DF … Victor Walendy, Matthias Girndt, and Daniel Frederik Greinert … Daniel
Greinert and Dr. V. Walendy dont receive any funding, grants fee …
Greinert and Dr. V. Walendy dont receive any funding, grants fee …
MP451 BIOIMPEDANCE GUIDED DRY WEIGHT IN HEMODIALYSIS PATIENTS-COMPARISON OF METHODS
E Seibert, D Greinert, O Dorligjav, S Mueller… - 2016 - academic.oup.com
Methods: We retrospectively analyzed The Department of Nephrology, Zagreb University
Hospital Center's database from 1982 to 2014 to test the safety of TPE. The complications were …
Hospital Center's database from 1982 to 2014 to test the safety of TPE. The complications were …
Procedural and clinical outcomes of patients undergoing a TAVI in TAVI procedure: Rationale and design of the multicentre, prospective, observational ReTAVI …
…, JN Skipirzepa, J Kurucova, D Greinert… - European journal of … - pubmed.ncbi.nlm.nih.gov
Background Transcatheter aortic valve implantation (TAVI) is increasingly being used in
younger patients and those with lower peri-procedural risk, meaning more patients will live long …
younger patients and those with lower peri-procedural risk, meaning more patients will live long …
[CITATION][C] Alemtuzumab induced anti‐glomerular basement syndrome in a patient with relapsing‐remitting multiple sclerosis
V Walendy, D Greinert - Neurology and Clinical Neuroscience, 2020 - Wiley Online Library
A 34 year old man, with a known history of Relapsing-Remitting-Multiple-Sclerosis (RRMS)
and no other comorbidities, was referred to our center, initially presenting with abrupt onset …
and no other comorbidities, was referred to our center, initially presenting with abrupt onset …